Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced the commercial launch of paired-end sequencing on its UG200™ Series and the availability of Solaris™ 2.0 ...

Comparative analysis of five maize lines prioritized candidate genes and variants within lethal-necrosis QTL, including PDLP5 ...

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its ...

Genomics England research finds support for genomics, but concerns remain over data protection, fairness and NHS readiness.

Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.

Gene by Gene, a leading genomics laboratory specializing in high-throughput sequencing and precision medicine, today announced a research collaboration with Children's Mercy to provide Whole Genome ...

Hundreds of patient-derived cancer models expanded dependency mapping and revealed vulnerabilities linked to mutations, ...

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2026 before U.S. markets open on Tuesday, ...

Researchers linked a family’s novel LPL variant to impaired LPL release, although they did not diagnose any family members ...

Genomics has transitioned from a specialized laboratory practice to a routine scientific method, driven by the increased ...

Nabsys 2.0, LLC ("Nabsys") today announced it will present preliminary data on Electronic Genome Mapping (EGM) in hematologic ...

Across follow-up, tirzepatide exposure was associated with fewer major adverse liver outcomes and hospitalizations in ...